---
figid: PMC12029365__molecules-30-01763-g004
figtitle: TME lactate signaling
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12029365
filename: molecules-30-01763-g004.jpg
figlink: /pmc/articles/PMC12029365/figure/F4/
number: F4
caption: TME lactate signaling. Lactates produced from ALDH1A3/PKM2 activation or
  secreted from CAFs, other stromal cells, and cancer cells can either shuttle through
  MCT1/4 lactate transporters or functions as a signaling molecule by binding to GRP132
  or HCAR1. Downstream effects of these signaling include activating immune cells
  and inducing their differentiation, stimulating cancer cell EMT, triggering angiogenesis,
  enhancing chemoresistance, and enabling cancer cell escape from immune surveillance.
  The question mark represents yet to be verified signaling pathway triggered by lactate
papertitle: 'Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant,
  and Therapeutic Target?'
reftext: Eugene Y. Kim, et al. Molecules. 2025 Apr;30(8).
year: '2025'
doi: 10.3390/molecules30081763
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: lactate | tumor microenvironment (TME) | cell metabolism | signaling and
  gene regulation | posttranslational modification | immune regulation
automl_pathway: 0.9414395
figid_alias: PMC12029365__F4
figtype: Figure
redirect_from: /figures/PMC12029365__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12029365__molecules-30-01763-g004.html
  '@type': Dataset
  description: TME lactate signaling. Lactates produced from ALDH1A3/PKM2 activation
    or secreted from CAFs, other stromal cells, and cancer cells can either shuttle
    through MCT1/4 lactate transporters or functions as a signaling molecule by binding
    to GRP132 or HCAR1. Downstream effects of these signaling include activating immune
    cells and inducing their differentiation, stimulating cancer cell EMT, triggering
    angiogenesis, enhancing chemoresistance, and enabling cancer cell escape from
    immune surveillance. The question mark represents yet to be verified signaling
    pathway triggered by lactate
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC16A4
  - SLC16A3
  - CMA1
  - SLC16A1
  - MCAT
  - MCTS1
  - PKM
  - PKLR
  - ALDH1A3
  - TBX1
  - GPR132
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - AKT1
  - AKT2
  - AKT3
  - HCAR1
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - MTOR
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - KRAS
  - HRAS
  - NRAS
  - ITK
  - SLC22A3
  - AREG
  - TAFAZZIN
  - WWTR1
  - CD274
  - ABCB1
  - lactate
  - Ca2+
  - RAS
  - cancer
---
